BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21305317)

  • 21. Drivers underpinning the malignant transformation of giant cell tumour of bone.
    Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
    J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance.
    Zhang J; Dong J; Yang Z; Ma X; Zhang J; Li M; Chen Y; Ding Y; Li K; Zhang Z
    World J Surg Oncol; 2015 May; 13():168. PubMed ID: 25929323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of ADAM12 (Meltrin-alpha) gene in giant cell tumor of bone].
    Tian B; Wen J; Zhang M; Li Q; Xie D
    Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):350-2. PubMed ID: 11769731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
    Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
    Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases.
    Pazzaglia L; Conti A; Chiechi A; Novello C; Magagnoli G; Astolfi A; Pession A; Krenacs T; Alberghini M; Picci P; Benassi MS
    Histopathology; 2010 Jul; 57(1):59-72. PubMed ID: 20653781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
    Huang L; Xu J; Wood DJ; Zheng MH
    Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
    Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
    Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giant cell tumor of bone express p63.
    Dickson BC; Li SQ; Wunder JS; Ferguson PC; Eslami B; Werier JA; Turcotte RE; Kandel RA
    Mod Pathol; 2008 Apr; 21(4):369-75. PubMed ID: 18311114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
    Noh BJ; Park YK
    Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
    Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
    Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
    Mills BG; Frausto A
    Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
    Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
    Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
    Guenther R; Krenn V; Morawietz L; Dankof A; Melcher I; Schaser KD; Kasper HU; Kuban RJ; Ungethüm U; Sers C
    Pathol Res Pract; 2005; 201(10):649-63. PubMed ID: 16325507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
    Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of Exogenous RUNX2 in Giant Cell Tumor of Bone In Vitro.
    Jin YH; Zhang J; Zhu H; Fan GT; Zhou GX
    Orthop Surg; 2020 Apr; 12(2):668-678. PubMed ID: 32154660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
    Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
    Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
    [No Abstract]   [Full Text] [Related]  

  • 37. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.
    Okubo T; Saito T; Mitomi H; Takagi T; Torigoe T; Suehara Y; Kaneko K; Yao T
    Virchows Arch; 2013 Jul; 463(1):67-77. PubMed ID: 23748877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.
    Maues De Paula A; Vasiljevic A; Giorgi R; Gomez-Brouchet A; Aubert S; Leroy X; Duval H; de Pinieux G; Bouvier C
    Virchows Arch; 2014 Oct; 465(4):487-94. PubMed ID: 25100342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
    Lee CH; Espinosa I; Jensen KC; Subramanian S; Zhu SX; Varma S; Montgomery KD; Nielsen TO; van de Rijn M; West RB
    Mod Pathol; 2008 May; 21(5):531-9. PubMed ID: 18192965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.
    Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PF; Holloway AJ; Thomas DM
    Am J Pathol; 2005 Jul; 167(1):117-28. PubMed ID: 15972958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.